Publications:5
- Home
- Profiles
Howard M Grodman, MD
- About Me
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Publications
Selected Publications
- Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Pavlos Msaouel, Andrew L. Hong, Elizabeth A. Mullen, Michael B. Atkins, Cheryl Lyn Walker, Chung Han Lee, Marcus A. Carden, Giannicola Genovese, W. Marston Linehan, Priya Rao, Maria J. Merino, Howard Grodman, Jeffrey S. Dome, Conrad V. Fernandez, James I. Geller, Andrea B. Apolo, Najat C. Daw, H. Courtney Hodges, Marva Moxey-Mims, Darmood Wei, Donald P. Bottaro, Michael Staehler, Jose A. Karam, W. Kimryn Rathmell, Nizar M. Tannir. Clinical Genitourinary Cancer
- Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. Howard Grodman, Lawrence Wolfe, Cynthia Kretschmar. Pediatric Blood and Cancer
- Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Girish Dhall, Howard Grodman, Lingyun Ji, Stephen Sands, Sharon Gardner, Ira J. Dunkel, Geoffrey B. McCowage, Bianca Diez, Jeffrey C. Allen, Anjali Gopalan, Albert S. Cornelius, Amanda Termuhlen, Minnie Abromowitch, Richard Sposto, Jonathan L. Finlay. Pediatric Blood and Cancer
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Grodman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Grodman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.